SG Americas Securities, LLC - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 410 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$3,563,000
-88.1%
147,008
-89.8%
0.03%
-88.5%
Q4 2017$29,953,000
+242.7%
1,441,437
+136.3%
0.28%
+262.3%
Q3 2017$8,740,000
+1555.3%
609,944
+1897.7%
0.08%
+1440.0%
Q2 2017$528,000
-79.1%
30,532
-86.7%
0.01%
-77.3%
Q1 2017$2,529,000
+606.4%
229,275
+1471.8%
0.02%
+450.0%
Q3 2016$358,000
-18.1%
14,587
-32.7%
0.00%
+33.3%
Q2 2016$437,000
-94.3%
21,687
-92.5%
0.00%
-94.5%
Q1 2016$7,620,000
+101.5%
289,749
+679.0%
0.06%
+103.7%
Q4 2015$3,781,000
-15.3%
37,195
+48.7%
0.03%0.0%
Q3 2015$4,462,000
+105.0%
25,013
+155.2%
0.03%
+92.9%
Q2 2015$2,177,000
+5.1%
9,800
-6.0%
0.01%
+16.7%
Q1 2015$2,071,000
+66.7%
10,426
+20.2%
0.01%
+100.0%
Q4 2014$1,242,000
-93.7%
8,676
-94.2%
0.01%
-94.8%
Q3 2014$19,568,000
+4010.9%
149,148
+3849.9%
0.12%
+3733.3%
Q2 2014$476,000
+168.9%
3,776
+180.7%
0.00%
+200.0%
Q1 2014$177,000
-35.6%
1,345
-42.6%
0.00%0.0%
Q4 2013$275,000
-3.8%
2,345
-29.5%
0.00%0.0%
Q2 2013$286,0003,3280.00%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2013
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,373,210$47,796,00039.06%
Claren Road Asset Management, LLC 77,527$1,561,00018.46%
Okumus Fund Management Ltd. 4,242,012$85,434,00014.79%
Chou Associates Management 1,446,843$29,139,00011.12%
FARLEY CAPITAL L.P. 307,458$6,192,0009.65%
HAP Trading, LLC 3,129,700$112,397,0006.58%
Pershing Square Capital Management 21,591,122$434,845,0005.79%
NORTH TIDE CAPITAL, LLC 2,500,000$50,350,0005.61%
Convector Capital Management, LP 192,000$3,867,0005.34%
Nebula Capital Management, LP 31,770$640,0005.07%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders